HDAC3-IN-2 (compound 4i), a pyrazinyl hydrazide-based HDAC3 inhibitor with an IC50 of 14 nM, effectively targets triple-negative breast cancer cells. Demonstrating cytotoxic activity, HDAC3-IN-2 exhibits an IC50 of 0.55 µM against 4T1 cells and 0.74 µM a
Molecular Weight:
315.37
Formula:
C16H21N5O2
Target:
HDAC
* VAT and and shipping costs not included. Errors and price changes excepted
